This inventor holds 20 USPTO granted patents and 2 published patent applications, primarily in Nucleic Acid Detection. Top assignees: Gen-Probe, Inc., Invitrogen Corporation, Genicon Sciences Corporation. Active years: 1989-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
14 out of 841 
2 out of 143 
1 out of 2 Years Active: 1989-2012
Areas of Expertise:
Title: The Innovative Mind of David E Kohne
Introduction
David E Kohne, an accomplished inventor residing in La Jolla, California, has made significant contributions to the field of assay technology. With a remarkable portfolio of 20 patents, Kohne exemplifies the spirit of innovation, creating methods that enhance the detection of analytes in various samples.
Latest Patents
One of Kohne's latest patents focuses on an "Analyte assay using particulate labels." This groundbreaking method allows for the specific detection of one or more analytes in a sample. The technique involves associating analytes with scattered-light detectable particles. The particles are illuminated under specific conditions that generate scattered light visible to the human eye without requiring electronic amplification or magnification greater than 500 times. By detecting this scattered light, researchers can quantitatively analyze the presence of analytes, paving the way for improved diagnostic tools.
Career Highlights
Throughout his career, David E Kohne has collaborated with various companies, notably Gen-Probe, Inc., and has made valuable contributions to the industry. His extensive research and innovation have garnered him recognition within scientific and medical communities alike.
Collaborations
Kohne has worked alongside talented individuals, including Juan Yguerabide and Evangelina E Yguerabide, enhancing collaborative efforts in developing advanced technologies for analyte detection. Their teamwork has resulted in innovative solutions that push the boundaries of current scientific capabilities.
Conclusion
In conclusion, David E Kohne's dedication to innovation has resulted in significant advancements in analyte detection technology. His 20 patents reflect a commitment to improving methods that have a direct impact on research and diagnostics. As Kohne continues to push the boundaries of science, his contributions will undoubtedly leave a lasting legacy in the field of assay technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile